Search results for "glomerulopathy"

showing 2 items of 2 documents

The Glomerular Lesions in Endotheliotropic Hemolytic Nephroangiopathy (Hemolytic Uremic Syndrome, Malignant Nephrosclerosis, Post Partal Renal Insuff…

1982

The term "Endotheliotropic Hemolytic Nephroangiopathy" (EHN) comprises various clinically or pathomorphologically defined disease states with severe renal lesions (e.g. hemolytic uremic syndrome, malignant nephrosclerosis, post partum renal insufficiency) which, to date, have been considered as different entities. We attempted to assign accompanying glomerular changes based upon light and electron microscopy to the above mentioned clinical pictures and their various stages. The accordingly classified glomerular lesions (G1--G3 and Ga) are of critical importance in pathohistological differential diagnosis. Since it is assumed that fibrin is a causing event in the pathogenesis of the vascular…

AdultMalePathologymedicine.medical_specialtyEndotheliumBiopsyKidney GlomerulusDiseaseFibrinPathology and Forensic MedicinePathogenesisPregnancyGlomerulopathyBiopsymedicineHumansChildAgedFibrinNephrosclerosisbiologymedicine.diagnostic_testMalignant nephrosclerosisbusiness.industryInfantPuerperal DisordersCell BiologyAcute Kidney InjuryMiddle Agedmedicine.diseaseMicroscopy Electronmedicine.anatomical_structureChild PreschoolHemolytic-Uremic Syndromebiology.proteinFemaleDifferential diagnosisbusinessPathology - Research and Practice
researchProduct

Impact of Obesity in Kidney Diseases.

2021

The clinical consequences of obesity on the kidneys, with or without metabolic abnormalities, involve both renal function and structures. The mechanisms linking obesity and renal damage are well understood, including several effector mechanisms with interconnected pathways. Higher prevalence of urinary albumin excretion, sub-nephrotic syndrome, nephrolithiasis, increased risk of developing CKD, and progression to ESKD have been identified as being associated with obesity and having a relevant clinical impact. Moreover, renal replacement therapy and kidney transplantation are also influenced by obesity. Losing weight is key in limiting the impact that obesity produces on the kidneys by reduc…

obesityNutrition and DieteticsNutrition. Foods and food supplybariatric surgeryfatty kidneyReviewurologic and male genital diseasesKidney TransplantationglomerulopathyRisk FactorsCKDHumansTX341-641Kidney DiseasesESRDDialysisFood ScienceNutrients
researchProduct